Financial Results
Arab Pharmaceuticals (ADCI.CA) Reports its Financial Results for the Period Ending on 30/06/2026
Published at 27 September 2026 at 06:59Arab PharmaceuticalsRelated stock:Arab Pharmaceuticals stockAll Arab Pharmaceuticals disclosures
Disclosure summary
Company Name: Arab Pharmaceuticals
ISIN Code: EGS38321C013
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 30/06/2026
Net profit: 264,708,575
F/S Period: From 01/07/2024 to 30/06/2025
Net Comparative profit: 227,857,702
Audit Status: Audited
Source: Arab Pharmaceuticals
The Annual BoD Report (768 KB)
The Annual Corporates Governance Report (789 KB)
The TCFD & ESG Reports (614 KB)
ISIN Code: EGS38321C013
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 30/06/2026
Net profit: 264,708,575
F/S Period: From 01/07/2024 to 30/06/2025
Net Comparative profit: 227,857,702
Audit Status: Audited
Source: Arab Pharmaceuticals
The Annual BoD Report (768 KB)
The Annual Corporates Governance Report (789 KB)
The TCFD & ESG Reports (614 KB)